Project Grant R01DK144220
- This federal Project Grant award of $324,226.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports a pilot and feasibility evaluation of a "Food Prescription" (Food RX) program. The program aims to address food insecurity among youth with type 1 diabetes (T1D) by providing healthy food access combined with an evidence-based family behavioral...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $324,882 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, to conduct a pilot trial of an intervention to support initial type 2 diabetes self-management among younger adults with children. The goal is to develop effective behavior change interventions that can improve early glycemic outcomes and influence...
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This federal Project Grant award of $779,978 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to identify optimal supportive components and adaptive treatment sequences for improving diabetes outcomes and addressing unmet social needs among individuals with high HbA1c levels. The overarching goal is to conduct a 12-month Sequential Multiple Assignment Randomized Trial (SMART) to evaluate...
- The U.S. Department of Health and Human Services, through the Trans-NIH Research Support program (CFDA 93.310), awarded a $1,282,030 project grant to Yale University on January 28, 2025. The goal of the project, titled "Addressing Social Determinants of Health in Young Adults with Type 1 Diabetes through Comprehensive Assessment, Responsiveness, and Engagement (T1CARE)," is to test the feasibility and preliminary efficacy of a personalized intervention to address social and clinical...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $165,541 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Scripps Health, a nonprofit health system based in San Diego, California. The grant funding will be used to integrate continuous glucose monitoring (CGM) education into the Project DULCE diabetes self-management program to improve glycemic control in Latino adults with type 2 diabetes. Key...
- This $147,747 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to elucidate the pathways from socioeconomic status (SES) to glycemic control and the onset of diabetes complications, with a focus on understanding how treatment intensification patterns mediate this relationship. The research plan includes: 1) summarizing...
- This $310,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a feasibility study for an adaptive intervention to improve food security and maternal-child health. The study aims to determine the feasibility of recruitment and retention, as well as the potential effectiveness of interventions, including WIC referrals, care navigation,...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a mixed-methods study on adapting and developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The key objectives of the...
This Project Grant award of $248,905, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847), will support a study to implement and assess a social work-led screening and referral program to address social determinants of health, including food insecurity, among families of youth with Type 1 diabetes enrolled in California's Children's Services (CCS) program. The project aims to generate new knowledge on effective processes for identifying and addressing social needs that impact diabetes management and outcomes. Key activities include implementing the screening and referral program, evaluating its feasibility and acceptability, and comparing outcomes for CCS families receiving the intervention against a control group of youth with diabetes not enrolled in CCS. The project will leverage partnerships with community-based organizations across Los Angeles County to provide referrals and services to families identified with social needs. The award period is from September 1, 2025 to July 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $248.9k | 8/31/25 |